Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Min-101
2. Roluperidone Hydrochloride
1. 359625-79-9
2. Cyr-101
3. Min-101
4. Min-101 Free Base
5. 4p31i0m3bf
6. 2-((1-(2-(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one
7. Roluperidone (usan)
8. Roluperidone [usan]
9. 1h-isoindol-1-one, 2-((1-(2-(4-fluorophenyl)-2-oxoethyl)-4-piperidinyl)methyl)-2,3-dihydro-
10. Unii-4p31i0m3bf
11. Roluperidon
12. 2-((1-(2-(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)-2,3-dihydro-1h-isoindol-1-one
13. 2-({1-[2-(4-fluorophenyl)-2-oxoethyl]piperidin-4-yl}methyl)-2,3-dihydro-1h-isoindol-1-one
14. Cyr-101(roluperidone)
15. Roluperidone; Cyr-101
16. Roluperidone [inn]
17. Schembl5252391
18. Chembl4297605
19. Dtxsid10189512
20. Mt-210cyr-101
21. Ex-a3145
22. Mfcd28502826
23. Akos037643756
24. Cs-6971
25. Db13080
26. As-35144
27. Hy-19469
28. Db-086934
29. D11258
30. A1-49962
31. Q25100536
32. 2-[[1-[2-(4-fluorophenyl)-2-oxoethyl]piperidin-4-yl]methyl]-3h-isoindol-1-one
33. 2-({1-[2-(4-fluorophenyl)-2-oxoethyl]piperidin-4-yl}methyl)-2,3-dihydro-1h-isoindol-1-one; Min-101
34. 2-[[1-[2-(4-fluorophenyl)-2-oxoethyl]-4-piperidinyl]methyl]-2,3-dihydro-1h-isoindol-1-one
35. Yt7
Molecular Weight | 366.4 g/mol |
---|---|
Molecular Formula | C22H23FN2O2 |
XLogP3 | 3.2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 366.17435614 g/mol |
Monoisotopic Mass | 366.17435614 g/mol |
Topological Polar Surface Area | 40.6 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 538 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Roluperidone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Roluperidone, including repackagers and relabelers. The FDA regulates Roluperidone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Roluperidone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Roluperidone supplier is an individual or a company that provides Roluperidone active pharmaceutical ingredient (API) or Roluperidone finished formulations upon request. The Roluperidone suppliers may include Roluperidone API manufacturers, exporters, distributors and traders.
click here to find a list of Roluperidone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Roluperidone DMF (Drug Master File) is a document detailing the whole manufacturing process of Roluperidone active pharmaceutical ingredient (API) in detail. Different forms of Roluperidone DMFs exist exist since differing nations have different regulations, such as Roluperidone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Roluperidone DMF submitted to regulatory agencies in the US is known as a USDMF. Roluperidone USDMF includes data on Roluperidone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Roluperidone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Roluperidone suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Roluperidone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Roluperidone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Roluperidone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Roluperidone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Roluperidone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Roluperidone suppliers with NDC on PharmaCompass.
Roluperidone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Roluperidone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Roluperidone GMP manufacturer or Roluperidone GMP API supplier for your needs.
A Roluperidone CoA (Certificate of Analysis) is a formal document that attests to Roluperidone's compliance with Roluperidone specifications and serves as a tool for batch-level quality control.
Roluperidone CoA mostly includes findings from lab analyses of a specific batch. For each Roluperidone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Roluperidone may be tested according to a variety of international standards, such as European Pharmacopoeia (Roluperidone EP), Roluperidone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Roluperidone USP).
LOOKING FOR A SUPPLIER?